- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07503990
Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance
Effects of Manipulating Food Intake Sequence in the Pre-exercise Meal on Substrate Utilisation and Endurance Performance in Athletes
The goal of this clinical trial is to understand how consuming a pre-exercise meal in different food intake sequences affects substrate utilisation and endurance exercise performance in healthy trained athletes. Specifically, the main questions it aims to answer are:
- Does consuming the pre-exercise meal in different food intake sequences alter the whole-body utilisation of fat and CHO at rest and during prolonged exercise at moderate to heavy intensities?
- Does consuming the pre-execise meal in different food intake sequences alter time-trial performance?
- Does consuming the pre-exercise meal in different food intake sequences alter other metabolic and physiological responses before, during or after exercise (i.e., blood glucose, blood lactate, heart rate (HR), ratings of perceived exertion (RPE), appetite)?
To address these questions, researchers will compare eating the dietary sources of rapidly absorbed CHO at the end (CHO-last meal pattern) or at the start (CHO-first meal pattern) of a standardised pre-exercise meal, in a randomised, counterbalanced, crossover design. Two hours after starting the pre-exercise meal, participants will perform a 60-min submaximal test on a cycling ergometer at two different intensities (30 min at 90% of the ventilatory threshold (VT) 1 and 30 min at 50% VT1-VT2), followed by a 10-km cycling time trial (TT).
In the screening visit participants will:
- Be screened for cardiometabolic conditions
- Perform an 8-12-min graded exercise test to determine their maximal pulmonary oxygen uptake (VO2max) and non-invasive submaximal anchors of performance (VT 1 and VT 2)
- Be familiarised to the experimental procedures
In experimental visits participants will:
- Follow guidelines pertaining to dietary intake, exercise and sleep in the previous 24 hours
- Have a standardised test meal in either the CHO-last or CHO-first food intake sequence
- Have 3 drops of capillary blood (0,9 µL in total) collected to measure glucose and lactate pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
- Breathe into an indirect calorimetry mask for 5 min pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
- Wear a HR monitor continuously during submaximal exercise and the TT
- Rate their appetite on visual analogue scales pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, and 30 min post-TT
- Rate their perceived exertion on RPE scales every 15 min during submaximal exercise, post-TT and 30 min post-TT.
Data will be compared within-participant between food intake sequences using linear mixed-effects models with random intercepts, to account for repeated measurements, interindividual variability, and potential missing data.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: João Brito, PhD
- Email: joao.brito@fpf.pt
Study Contact Backup
- Name: Rita Giro
- Phone Number: 351 225074320
- Email: up201307940@edu.fcna.up.pt
Study Locations
-
-
Oeiras
-
Lisbon, Oeiras, Portugal, 1495-433
- Recruiting
- Cidade do Futebol
-
Contact:
- João Brito, PhD
- Phone Number: +351 213252700
- Email: joao.brito@fpf.pt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (18-64 years old)
- Men
- Endurance-trained athletes (meeting training and performance caliber criteria ≥Tier 2; McKay et al., 2022)
- Healthy (meeting the exclusion criteria for medical conditions)
- Normal glucose tolerant according to the latest criteria established by the American Diabetes Association (2024): HbA1c <5.7%, fasting plasma glucose <5.6 mmol/L (100 mg/dL) or 2-h plasma glucose <7.8 mmol/L (140 mg/dL) during a 75-g OGTT
- Able and willing to provide informed consent and safely comply with study procedures
Exclusion Criteria:
- Any medical condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias into the experiment (e.g. cardiovascular disease; alcohol or substance abuse; any condition affecting the glucose or lipid metabolism, reviewed on a case by case basis)
- Any reported medication or supplementation that may interfere with the glucose metabolism (e.g., acarbose, insulin, metformin, semaglutide, thiazolidinediones, sulfonylureas, corticosteroids, thiazide diuretics) or lipid metabolism (e.g., statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates, L-carnitine). Other medication and supplementation will be reviewed on a case by case basis.
- Known food allergy, intolerance or hypersensitivity to any of the test meal ingredients
- Recent change in body mass (± 2 kg in the last 2 months)
- Smoking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CL-CF
The interventions (carbohydrate-last meal pattern (CL) or carbohydrate-first meal pattern (CF)) will be delivered in random order at two study visits, separated by a wash-out period of at least 7 days.
If participants are allocated to this study arm, they will receive the CL on the first visit and the CF on the second visit.
The nutritional composition of the test-meal will comply to the current sports nutrition guidelines for the pre-exercise meal (i.e., 1-4 g of CHO/kg of body mass, moderate amounts of protein, low-fat and fibre content, 5-10 mL/kg of body mass of fluids) (Thomas et al., 2016).
Participants will be encouraged to consume the meal in full within 15 minutes, at a comfortable pace, to mimic real eating circumstances.
|
Skyr yoghurt, whey protein and almonds over ~5 min, immediately followed by white bread, strawberry jam, banana and pulp-free orange juice over ~10 min.
Other Names:
White bread, strawberry jam, banana and pulp-free orange juice over ~10 min, immediately followed by skyr yoghurt, whey protein and almonds over ~5 min.
Other Names:
|
|
Active Comparator: CF-CL
The interventions (carbohydrate-last meal pattern (CL) or carbohydrate-first meal pattern (CF)) will be delivered in random order at two study visits, separated by a wash-out period of at least 7 days.
If participants are allocated to this study arm, they will receive the CF on the first visit and the CL on the second visit.
The test-meal will be identical and isocaloric in both interventions of the study.
|
Skyr yoghurt, whey protein and almonds over ~5 min, immediately followed by white bread, strawberry jam, banana and pulp-free orange juice over ~10 min.
Other Names:
White bread, strawberry jam, banana and pulp-free orange juice over ~10 min, immediately followed by skyr yoghurt, whey protein and almonds over ~5 min.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Whole-body fat oxidation
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the whole-body fat oxidation rate (g/min) over time adjusted for baseline, measured by indirect calorimetry.
|
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
|
Time-trial performance
Time Frame: Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the time to complete (min:sec) a 10-km cycling TT, assessed using a validated cycle ergometer.
|
Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time-trial power output
Time Frame: Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the average power output (W) during a 10-km cycling TT, assessed using a validated cycle ergometer.
|
Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
|
|
Whole-body CHO oxidation
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the whole-body CHO oxidation rate (g/min) over time adjusted for baseline, measured by indirect calorimetry.
|
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
|
Respiratory exchange ratio (RER)
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the RER over time adjusted for baseline, measured by indirect calorimetry.
|
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
|
Energy expenditure
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
Difference between CHO-last and CHO-first meal patterns in the energy expenditure rate (kcal/min) over time adjusted for baseline, measured by indirect calorimetry.
|
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
|
|
Blood glucose concentrations
Time Frame: Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
|
Difference between CHO-last and CHO-first meal patterns in the capillary blood glucose concentrations (mmol/L) over time adjusted for baseline, measured by a validated glucometer.
|
Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
|
|
Blood lactate concentrations
Time Frame: Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
|
Difference between CHO-last and CHO-first meal patterns in the capillary blood lactate concentrations (mmol/L) over time adjusted for baseline, measured by a validated lactate meter.
|
Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
|
|
Heart Rate
Time Frame: Continuously throughout the standardised exercise protocol (120-180 minutes) and subsequent time trial
|
Difference between CHO-last and CHO-first meal patterns in the heart rate (bpm) over time adjusted for baseline, assessed as 15-minute averages during exercise using a validated heart rate monitor.
|
Continuously throughout the standardised exercise protocol (120-180 minutes) and subsequent time trial
|
|
Ratings of perceived exertion (RPE)
Time Frame: Every 15 minutes during the standardised exercise protocol (120-180 minutes), immediately upon completion of the subsequent time trial, 30 minutes after completion of the time trial
|
Difference between CHO-last and CHO-first meal patterns in the absolute RPE over time, assessed during and after exercise using the validated modified Borg's 0-10 scale.
|
Every 15 minutes during the standardised exercise protocol (120-180 minutes), immediately upon completion of the subsequent time trial, 30 minutes after completion of the time trial
|
|
Subjective appetite ratings
Time Frame: Every 15 minutes post-meal in the first hour (0-60 minutes), every 30 minutes in the second hour (60-120 minutes), and 30 minutes after completion of the time trial
|
Difference between CHO-last and CHO-first meal patterns in the appetite ratings (mm) over time adjusted for baseline, assessed at rest and after exercise using validated 100-mm visual analogue scales.
|
Every 15 minutes post-meal in the first hour (0-60 minutes), every 30 minutes in the second hour (60-120 minutes), and 30 minutes after completion of the time trial
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rita Giro, FCNAUP, University of Porto; Federação Portuguesa de Futebol
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FOODSEQ-SUEP
- 2022.12954.BD (Other Grant/Funding Number: Fundação para a Ciência e Tecnologia)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Touro University, CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy Participants | Obese But Otherwise Healthy ParticipantsUnited States
-
Beijing Tide Pharmaceutical Co., LtdRecruitingHealthy | Healthy ParticipantsChina
-
Aston UniversityCooperVision, Inc.Enrolling by invitationHealthy | Healthy ParticipantsUnited Kingdom
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Standard Process Inc.Recruiting
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
Hoffmann-La RocheNot yet recruiting
-
Simcere Pharmaceutical Co., LtdNot yet recruiting
Clinical Trials on Carbohydrate-last meal pattern
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolCompletedHealthy | Sleep | Exercise | Dietary Intervention | Nutrition | Glycemic VariabilityPortugal
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolCompletedHealthy | Craving | Postprandial Hyperglycemia | Nutrition, Healthy | HungerPortugal
-
Old Dominion UniversityRecruitingGlucose Metabolism Disorders | Hunger | Fat BurnUnited States
-
Old Dominion UniversityCompleted
-
University of JordanEnrolling by invitationSleep Quality | Circadian Rhythm | Meal Timing | Medical Residents | Nutrition IntakeJordan
-
Weill Medical College of Cornell UniversityCompletedType 2 DiabetesUnited States
-
University of NottinghamCompletedNitrogen BalanceUnited Kingdom
-
University of NottinghamCompletedObesity | Metabolic DisturbanceUnited Kingdom
-
Purdue UniversityCompletedBioavailability | Dietary Modification | Carotenoid
-
University of NottinghamCompletedObesity | Metabolic SyndromeUnited Kingdom